BAM
RMD icon

BTS Asset Management’s ResMed RMD Stock Holding History

BTS Asset Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$292K Buy
+1,301
New +$324K 1.13% 26

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BTS Asset Management's RMD Position: Q1 2026 in Review

BTS Asset Management opened a new position in ResMed (RMD) in Q1 2026: 1,301 shares worth $292K. The stake represents 1.13% of the portfolio and ranks #26 among its holdings.

938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • BTS Asset Management held 1,301 shares of ResMed worth $292K as of Q1 2026.
  • ResMed was a new BTS Asset Management position in Q1 2026.
  • ResMed made up 1.13% of BTS Asset Management's portfolio in Q1 2026, its #26 holding.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on BTS Asset Management's 13F filing for Q1 2026, filed 13 May 2026.